About this trial
This study aims to compare the effectiveness of extracorporeal shock wave therapy (ESWT) versus structured therapeutic exercise in patients with chronic knee osteoarthritis (KOA), with respect to pain reduction and improvement of knee function.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults ≥ 40 years with clinical and radiographic diagnosis of chronic knee osteoarthritis (KOA) (Kellgren-Lawrence grade II-III).
Both sexes.
Persistent knee pain ≥ 3 months.
Ability to provide consent and participate in interventions.
Disqualifiers
Prior knee surgery within last 6 months.
Intra-articular injections in the last 3 months.
Systemic inflammatory arthritis or other neurological conditions affecting gait.
Trial design
Parallel
Treatments tested in this trial
Extracorporeal shock wave therapy
Other interventionPatients will receive extracorporeal shock wave therapy.
Exercise therapy program
Other interventionPatients will undergo a structured exercise therapy program.
Treatment groups
Trial outcomes
Primary outcomes
Change in pain intensity
Change in pain intensity will be assessed using the Visual Analogue Scale (VAS) which is a 10-cm horizontal line used to measure pain intensity, ranging from (0) "no pain" to (10) "worst imaginable pain".
Secondary outcomes
Stiffness assessment
Stiffness will be assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). WOMAC will be recorded at baseline, at the end of the intervention period, and during follow-up. Higher scores indicate greater symptom severity.
Assessment of physical function
Physical function will be assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). WOMAC will be recorded at baseline, at the end of the intervention period, and during follow-up. Higher scores indicate greater symptom severity.
Knee range of motion
Knee range of motion (ROM) will be assessed.
Incidence of adverse events
Incidence of adverse events will be recorded.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.